About
Correctsequence develops precision therapies using proprietary base editing technology to treat genetic diseases such as sickle cell anemia and beta-thalassemia.
Explore Correctsequence's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.